Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Catalyst Pharmaceuticals Inc    CPRX

Delayed Quote. Delayed  - 04/29 09:59:52 pm
0.68 USD   +7.10%
04/26 TUESDAY SECTOR : Biotechnology, Drugs
04/26 Catalyst Pharmaceuticals Provides Regulatory Update on Firdapse
03/15 CATALYST PHARMA : reports 4Q loss
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/25/2016 04/26/2016 04/27/2016 04/28/2016 04/29/2016 Date
1.24(c) 0.63(c) 0.6301(c) 0.6349(c) 0.68 Last
789 653 13 384 123 4 735 763 1 305 896 3 190 382 Volume
+2.48% -49.19% +0.02% +0.76% +7.10% Change
More quotes
Financials ($)
Sales 2016 -
EBIT 2016 -26,7 M
Net income 2016 -32,2 M
Debt 2016 -
Yield 2016 -
Sales 2017 32,6 M
EBIT 2017 -22,1 M
Net income 2017 -3,40 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 0
Capi. / Sales 2017 1,62x
Capitalization 52,6 M
More Financials
Company
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company.It focuses on development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms, and Tourette’s disorder.The... 
More about the company
Surperformance© ratings of Catalyst Pharmaceuticals I
Trading Rating : Investor Rating : -
More Ratings
Latest news on CATALYST PHARMACEUTICALS I
04/26 TUESDAY SECTOR LAGGARDS : Biotechnology, Drugs
04/26 Catalyst Pharmaceuticals Provides Regulatory Update on Firdapse
03/15 CATALYST PHARMACEUTICALS : reports 4Q loss
03/15 Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2015 Financial..
03/11 CATALYST PHARMACEUTICALS : to Present at the 28th Annual ROTH Conference
03/10 Catalyst Pharmaceuticals to Present at the 28th Annual ROTH Conference
03/09 Catalyst Pharmaceuticals to Hold Fourth Quarter Financial Results Conference ..
03/01 CATALYST PHARMACEUTICALS : Observes Rare Disease Day 2016
More news
Sector news : Bio Therapeutic Drugs
04:29pDJMedivation Rejects Sanofi's $9.3 Billion Takeover Bid--Update
04:15pDJMedivation Rejects Sanofi's Takeover Bid
04:01pDJMedivation Rejects Sanofi's $9.3 Billion Takeover Bid
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
04/26 Midday Gainers/ Losers
04/26 Catalyst Pharma down 48% after FDA says new Phase 3 study needed for Firdapse..
04/26 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
03/16 Catalyst Pharmaceutical Partners' (CPRX) CEO Pat McEnany on Q4 2015 Results -..
03/15 Catalyst Pharmaceutical EPS in-line


Comments 
Advertisement
Chart CATALYST PHARMACEUTICALS I
Duration : Period :
Catalyst Pharmaceuticals I Technical Analysis Chart | CPRX | US14888U1016 | 4-Traders
Full-screen chart
Technical analysis trends CATALYST PHARMACE...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions